These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 32087483)

  • 1. Probabilistic human health risk assessment of perfluorooctane sulfonate (PFOS) by integrating in vitro, in vivo toxicity, and human epidemiological studies using a Bayesian-based dose-response assessment coupled with physiologically based pharmacokinetic (PBPK) modeling approach.
    Chou WC; Lin Z
    Environ Int; 2020 Apr; 137():105581. PubMed ID: 32087483
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bayesian evaluation of a physiologically based pharmacokinetic (PBPK) model for perfluorooctane sulfonate (PFOS) to characterize the interspecies uncertainty between mice, rats, monkeys, and humans: Development and performance verification.
    Chou WC; Lin Z
    Environ Int; 2019 Aug; 129():408-422. PubMed ID: 31152982
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integration of Toxicogenomics and Physiologically Based Pharmacokinetic Modeling in Human Health Risk Assessment of Perfluorooctane Sulfonate.
    Chen Q; Chou WC; Lin Z
    Environ Sci Technol; 2022 Mar; 56(6):3623-3633. PubMed ID: 35194992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of a Gestational and Lactational Physiologically Based Pharmacokinetic (PBPK) Model for Perfluorooctane Sulfonate (PFOS) in Rats and Humans and Its Implications in the Derivation of Health-Based Toxicity Values.
    Chou WC; Lin Z
    Environ Health Perspect; 2021 Mar; 129(3):37004. PubMed ID: 33730865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk Assessment of Perfluorooctane Sulfonate (PFOS) using Dynamic Age Dependent Physiologically based Pharmacokinetic Model (PBPK) across Human Lifetime.
    Deepika D; Sharma RP; Schuhmacher M; Kumar V
    Environ Res; 2021 Aug; 199():111287. PubMed ID: 34000270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Species- and Tissue-Specific Avian Chronic Toxicity Values for Perfluorooctane Sulfonate (PFOS) and a Binary Mixture of PFOS and Perfluorohexane Sulfonate.
    Dennis NM; Subbiah S; Karnjanapiboonwong A; Dennis ML; McCarthy C; Salice CJ; Anderson TA
    Environ Toxicol Chem; 2021 Mar; 40(3):899-909. PubMed ID: 33210750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Framework for risk assessment of PFAS utilizing experimental studies and in-silico models.
    Deepika D; Rovira J; Sabuz Ó; Balaguer J; Schuhmacher M; Domingo JL; Kumar V
    Environ Res; 2022 May; 208():112722. PubMed ID: 35026182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Associations of Perfluoroalkyl Substances (PFAS) with Lower Birth Weight: An Evaluation of Potential Confounding by Glomerular Filtration Rate Using a Physiologically Based Pharmacokinetic Model (PBPK).
    Verner MA; Loccisano AE; Morken NH; Yoon M; Wu H; McDougall R; Maisonet M; Marcus M; Kishi R; Miyashita C; Chen MH; Hsieh WS; Andersen ME; Clewell HJ; Longnecker MP
    Environ Health Perspect; 2015 Dec; 123(12):1317-24. PubMed ID: 26008903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessing the human health risks of perfluorooctane sulfonate by in vivo and in vitro studies.
    Zeng Z; Song B; Xiao R; Zeng G; Gong J; Chen M; Xu P; Zhang P; Shen M; Yi H
    Environ Int; 2019 May; 126():598-610. PubMed ID: 30856447
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PBPK modeling for PFOS and PFOA: validation with human experimental data.
    Fàbrega F; Kumar V; Schuhmacher M; Domingo JL; Nadal M
    Toxicol Lett; 2014 Oct; 230(2):244-51. PubMed ID: 24440341
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The derivation of a Reference Dose (RfD) for perfluorooctane sulfonate (PFOS) based on immune suppression.
    Pachkowski B; Post GB; Stern AH
    Environ Res; 2019 Apr; 171():452-469. PubMed ID: 30739020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toxicokinetics of perfluorooctane sulfonate in rabbits under environmentally realistic exposure conditions and comparative assessment between mammals and birds.
    Tarazona JV; Rodríguez C; Alonso E; Sáez M; González F; San Andrés MD; Jiménez B; San Andrés MI
    Toxicol Lett; 2016 Jan; 241():200-6. PubMed ID: 26562771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Probabilistic risk assessment of gold nanoparticles after intravenous administration by integrating in vitro and in vivo toxicity with physiologically based pharmacokinetic modeling.
    Cheng YH; Riviere JE; Monteiro-Riviere NA; Lin Z
    Nanotoxicology; 2018 Jun; 12(5):453-469. PubMed ID: 29658401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediction of maternal and foetal exposures to perfluoroalkyl compounds in a Spanish birth cohort using toxicokinetic modelling.
    Brochot C; Casas M; Manzano-Salgado C; Zeman FA; Schettgen T; Vrijheid M; Bois FY
    Toxicol Appl Pharmacol; 2019 Sep; 379():114640. PubMed ID: 31251942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative bias analysis of a reported association between perfluoroalkyl substances (PFAS) and endometriosis: The influence of oral contraceptive use.
    Ngueta G; Longnecker MP; Yoon M; Ruark CD; Clewell HJ; Andersen ME; Verner MA
    Environ Int; 2017 Jul; 104():118-121. PubMed ID: 28392065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Environmental perfluorooctane sulfonate exposure drives T cell activation in bottlenose dolphins.
    Soloff AC; Wolf BJ; White ND; Muir D; Courtney S; Hardiman G; Bossart GD; Fair PA
    J Appl Toxicol; 2017 Sep; 37(9):1108-1116. PubMed ID: 28425113
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Probabilistic Approach to Evaluate the Risk of Decreased Total Triiodothyronine Hormone Levels following Chronic Exposure to PFOS and PFHxS via Contaminated Drinking Water.
    Silva AV; Ringblom J; Lindh C; Scott K; Jakobsson K; Öberg M
    Environ Health Perspect; 2020 Jul; 128(7):76001. PubMed ID: 32639173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toxicokinetics of perfluorooctane sulfonate in birds under environmentally realistic exposure conditions and development of a kinetic predictive model.
    Tarazona JV; Rodríguez C; Alonso E; Sáez M; González F; San Andrés MD; Jiménez B; San Andrés MI
    Toxicol Lett; 2015 Jan; 232(2):363-8. PubMed ID: 25445721
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exposure to perfluorooctane sulfonate reduced cell viability and insulin release capacity of β cells.
    Qin W; Ren X; Zhao L; Guo L
    J Environ Sci (China); 2022 May; 115():162-172. PubMed ID: 34969446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perfluorooctane sulfonate alternatives and metabolic syndrome in adults: New evidence from the Isomers of C8 Health Project in China.
    Yu S; Feng WR; Liang ZM; Zeng XY; Bloom MS; Hu GC; Zhou Y; Ou YQ; Chu C; Li QQ; Yu Y; Zeng XW; Dong GH
    Environ Pollut; 2021 Aug; 283():117078. PubMed ID: 33839621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.